ESj- Powder Complete T&A Study
Study Details
Study Description
Brief Summary
The goal of this study is to gather data on the tolerance and acceptability of a new ONS (ESj-powder complete) in children currently taking ONS.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The goal of this study is to demonstrate the tolerance and acceptability of the test product when consumed by children who are currently prescribed (a similar) ONS. The data generated from this study will be submitted to the ACBS, who will consider it for reimbursement as a Food for Special Medical Purpose (FSMP) in the UK.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: EnergieShake® Junior Powder Complete (test) EnergieShake® Junior Powder Complete will be consumed by children, as a supplement to normal diet, over a period of 7 day period to determine its acceptability (liking, compliance) and tolerance (gastro-intestinal tolerance). The dose will be the same as currently consumed product (all children recruited to the study will be consuming an oral nutritional supplement). |
Other: EnergieShake® Junior Powder Complete
Oral Nutritional Supplement
|
Outcome Measures
Primary Outcome Measures
- Acceptability & Tolerance: questionnaire [7 days]
Acceptability of test product will be tested in children using a questionnaire with a liking scale (Liking Scale - 1-10 - 0 being dislike and 10 being like a lot) and compliance (intake/day versus prescribed dose) of the test product over a 7 day period and compared to acceptability when consuming their current oral nutritional supplement
- Gastrointestinal Tolerance [7 days]
Gastrointestinal (GI) tolerance of test product will be determined in children using a questionnaire detailing daily bowel habits and symptoms that occur (new or worsening) while consuming the test product over a 7 day period and compared to GI tolerance when consuming their current oral nutritional supplement. This is established using a combination of the Bristol Stool Chart scoring (BSC - type 1 up to type 7) before and during the study along with number of bowel movements/day and stool consistency.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
1-18 years of age
-
Children currently prescribed and consuming Oral Nutritional Supplements (ONS)
-
Willingness to take part in the study, and consent to the study protocol signed by parent/guardian or older child (when appropriate)
Exclusion Criteria:
Participants requiring exclusive enteral tube feeding
-
Participants on parenteral nutrition
-
Participants with cow's milk or soy allergy or lactose intolerance
-
Participants with galactosaemia
-
Participants with a chronic renal or liver disease
-
Participants who are acutely unwell
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Brighton & Sussex NHS Trust | Brighton | United Kingdom | BN2 5BE | |
| 2 | Leeds Children's Hospital, | Leeds | United Kingdom | LS2 9NS | |
| 3 | Great Ormond Street Hospital Foundation Trust | London | United Kingdom | WC1N 3JH |
Sponsors and Collaborators
- Anaiah Healthcare Pvt Ltd
- Brighton and Sussex University Hospitals NHS Trust
- Great Ormond Street Hospital for Children NHS Foundation Trust
- The Leeds Teaching Hospitals NHS Trust
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ESj-01